Chemoinformaics analysis of 12-Hydroxyoctadecanoic acid
| Molecular Weight | 300.483 | nRot | 16 |
| Heavy Atom Molecular Weight | 264.195 | nRig | 1 |
| Exact Molecular Weight | 300.266 | nRing | 0 |
| Solubility: LogS | -4.203 | nHRing | 0 |
| Solubility: LogP | 5.809 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 56.4705 |
| nHD | 2 | BPOL | 36.9835 |
| QED | 0.38 |
| Synth | 2.411 |
| Natural Product Likeliness | 0.776 |
| NR-PPAR-gamma | 0.985 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.039 |
| Pgp-sub | 0.012 |
| HIA | 0.014 |
| CACO-2 | -5.138 |
| MDCK | 0.0000356 |
| BBB | 0.085 |
| PPB | 0.978813 |
| VDSS | 0.505 |
| FU | 0.0129541 |
| CYP1A2-inh | 0.144 |
| CYP1A2-sub | 0.202 |
| CYP2c19-inh | 0.074 |
| CYP2c19-sub | 0.091 |
| CYP2c9-inh | 0.165 |
| CYP2c9-sub | 0.986 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.058 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.015 |
| CL | 4.116 |
| T12 | 0.708 |
| hERG | 0.052 |
| Ames | 0.004 |
| ROA | 0.006 |
| SkinSen | 0.902 |
| Carcinogencity | 0.053 |
| EI | 0.963 |
| Respiratory | 0.53 |
| NR-Aromatase | 0.091 |
| Antiviral | Yes |
| Prediction | 0.548875 |